Investing With IBD

Mike Webster, senior market strategist at IBD, joins Investor’s Business Daily’s “Investing with IBD” podcast to discuss the current market and explain the dangers of downside reversals. Plus, we take a look at some stocks worthy of your watchlist including CrowdStrike (CRWD), ServiceNow (NOW) and Amazon (AMZN). Learn more about your ad choices. Visit megaphone.fm/adchoices

Market indecision can make money for savvy investors, but only if you’re able to act faster than the market. John Kosar, president and chief market strategist at Asbury Research, talks about modeling a unique period in the market and the contractions in models and rate cuts. Learn why volatility opens up opportunities in stocks like Apple (AAPL) and Microsoft (MSFT). Learn more about your ad choices. Visit megaphone.fm/adchoices

It’s hard to sell when you’re making money — but that’s when sell rules matter the most. Joe Fahmy, portfolio manager at Zor Capital, joins Investor’s Business Daily’s “Investing with IBD” podcast to talk about selling strategies for winners, because they don't run forever, as well as laggards. Plus, he shares where he thinks we are in the current bull cycle and how much room Nvidia and other AI leaders have left to run. Learn more about your ad choices. Visit megaphone.fm/adchoices

Exploring the tricks, traps and tools behind the best trades. David Saito-Chung, deputy markets editor at IBD, joins Investor’s Business Daily’s “Investing with IBD” podcast to examine the rise (and decline) of Skechers, discuss why a distraction led Irusha to miss this stock’s run and how to trade in the spirit of Bill O’Neil. Learn more about your ad choices. Visit megaphone.fm/adchoices

Frothy sentiment and a market behaving the opposite of what’s expected is enough to worry even seasoned investors. Jeffrey Hirsch, editor of the Stock Trader’s Almanac, joins Investor’s Business Daily’s “Investing With IBD” podcast to talk about how historical models are impacting his election year outlook. While there might be some short-term chop, seasonality suggests a strong second half. Hirsch explains. Learn more about your ad choices. Visit megaphone.fm/adchoices

From Tesla (TSLA) to self driving, Elon Musk’s gravitational pull with investors is undeniable. But will AI dreams and automotive leadership be enough to overcome questions about Musk’s volatile management, the stock’s unrealized potential and a $46 billion pay raise request? Simon Erickson, founder and CEO of 7investing, joins Investor’s Business Daily’s “Investing with IBD” podcast to explain. Learn more about your ad choices. Visit megaphone.fm/adchoices

The market barometers are speaking — are you listening? Jim Roppel, founder of The Roppel Report, joins Investor’s Business Daily’s “Investing with IBD” podcast to discuss what major U.S. stocks, crypto and commodities are telling the market. Take an in-depth look at Amazon and Nvidia and learn why earnings from retailers around the world like MercadoLibre and PDD Holdings matter. Learn more about your ad choices. Visit megaphone.fm/adchoices

Katie Stockton, founder and managing partner of Fairlead Strategies, joins Investor’s Business Daily’s “Investing with IBD” podcast to discuss short-term market takeaways — and long-term momentum in stocks. Learn how to apply technical indicators to determine resistance levels in stocks like Amazon (AMZN) and why ETFs like VanEck Agribusiness (MOO) and stocks like General Mills (GIS) could be smart places to wait out potentially volatile periods. Learn more about your ad choices. Visit megaphone.fm/adchoices

After years of hype, investors now want tech companies to show them the money. Jeremy C. Owens, tech editor at MarketWatch, joins Investor’s Business Daily’s “Investing with IBD” podcast to discuss earnings, AI and tech cycles. Learn why generative AI is in fact a story about business enterprise spending and why “The Trillionaires” like Microsoft (MSFT), Meta (META) and Alphabet (GOOGL) vary in their approaches to AI — and to profits. Learn more about your ad choices. Visit megaphone.fm/adchoices

Don’t lower your standards. Dan Fitzpatrick joins Investor Business Daily’s “Investing with IBD” podcast to talk about taking a step back from the market, focusing on the leaders and why consistency is key in trading. Learn why Novo Nordisk (NVO) could be set to go higher and what’s great about Goldman Sachs (GS). Learn more about your ad choices. Visit megaphone.fm/adchoices